EP 1480964 A1 20041201 - INHIBITEURS DE L'ANGIOGENESE
Title (en)
INHIBITEURS DE L'ANGIOGENESE
Title (de)
ANGIOGENESE-INHIBITOREN
Title (fr)
INHIBITEURS DE L'ANGIOGENESE
Publication
Application
Priority
- FR 0203721 W 20021029
- FR 0114542 A 20011109
Abstract (en)
[origin: WO03040119A1] The invention concerns novel 1-oxa-spiro [2, 5] octan-6-ol of general formula (I), as well as their preparation method, and their use in pharmaceutical compositions for use in human or veterinary medicine, or in cosmetic compositions.
IPC 1-7
IPC 8 full level
A61K 8/00 (2006.01); A61K 8/49 (2006.01); A61K 31/336 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 17/10 (2006.01); A61P 27/00 (2006.01); A61P 27/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); A61Q 5/00 (2006.01); A61Q 19/00 (2006.01); C07B 53/00 (2006.01); C07D 301/02 (2006.01); C07D 303/22 (2006.01)
CPC (source: EP)
A61K 8/4973 (2013.01); A61P 3/10 (2017.12); A61P 9/10 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 17/10 (2017.12); A61P 19/02 (2017.12); A61P 27/00 (2017.12); A61P 27/06 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); A61Q 19/00 (2013.01); C07D 303/22 (2013.01)
Citation (search report)
See references of WO 03040119A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated extension state (EPC)
LT LV RO SI
DOCDB simple family (publication)
WO 03040119 A1 20030515; WO 03040119 A8 20031127; AR 037341 A1 20041103; EP 1480964 A1 20041201; FR 2832149 A1 20030516; FR 2832149 B1 20060106; JP 2005519026 A 20050630
DOCDB simple family (application)
FR 0203721 W 20021029; AR P020104286 A 20021108; EP 02795355 A 20021029; FR 0114542 A 20011109; JP 2003542165 A 20021029